Usage summary
Strongest role: Inclusion Required
Inclusion-required count: 47
Treatment-assignment count: 0
Stratification count: 1
solid tumor basket · Therapy Not Normalized
ALK fusion is flagged as manual review required because public trials show inclusion required evidence in 62 contexts. FDA CDx context should be reviewed manually.
Strongest role: Inclusion Required
Inclusion-required count: 47
Treatment-assignment count: 0
Stratification count: 1
Threshold count: 12
Common snippets: MSI-H | BRAF V600E | BRAF V600E
Threshold label: Moderate
CDx label: Fda Cdx Context Manual Review Required
CDx maturity score: 2/5
Confidence: Low
Signal count: 0
Recent signals: 0
Density label: Low
https://clinicaltrials.gov/study/NCT03698994 | https://clinicaltrials.gov/study/NCT04810208 | https://clinicaltrials.gov/study/NCT00390052 | https://clinicaltrials.gov/study/NCT01240538 | https://clinicaltrials.gov/study/NCT01773421 | https://clinicaltrials.gov/study/NCT00096005 | https://clinicaltrials.gov/study/NCT03355066 | https://clinicaltrials.gov/study/NCT03220035 | https://clinicaltrials.gov/study/NCT03868423 | https://clinicaltrials.gov/study/NCT01266460 | https://clinicaltrials.gov/study/NCT00769288 | https://clinicaltrials.gov/study/NCT03210714 | https://clinicaltrials.gov/study/NCT02952248 | https://clinicaltrials.gov/study/NCT01876043 | https://clinicaltrials.gov/study/NCT07259889 | https://clinicaltrials.gov/study/NCT04898543 | https://clinicaltrials.gov/study/NCT06656390 | https://clinicaltrials.gov/study/NCT00951158 | https://clinicaltrials.gov/study/NCT01421524 | https://clinicaltrials.gov/study/NCT04042831 | https://clinicaltrials.gov/study/NCT05114668 | https://clinicaltrials.gov/study/NCT00356889 | https://clinicaltrials.gov/study/NCT02844439 | https://clinicaltrials.gov/study/NCT02650401 | https://clinicaltrials.gov/study/NCT06333899 | https://clinicaltrials.gov/study/NCT06790589 | https://clinicaltrials.gov/study/NCT04774718 | https://clinicaltrials.gov/study/NCT03155620 | https://clinicaltrials.gov/study/NCT03375437 | https://clinicaltrials.gov/study/NCT04094610 | https://clinicaltrials.gov/study/NCT04423185 | https://clinicaltrials.gov/study/NCT04671849 | https://clinicaltrials.gov/study/NCT06006793 | https://clinicaltrials.gov/study/NCT06820255 | https://clinicaltrials.gov/study/NCT04873375 | https://clinicaltrials.gov/study/NCT06954116 | https://clinicaltrials.gov/study/NCT03738228 | https://clinicaltrials.gov/study/NCT00905060 | https://clinicaltrials.gov/study/NCT07140679 | https://clinicaltrials.gov/study/NCT06897527 | https://clinicaltrials.gov/study/NCT04450901 | https://clinicaltrials.gov/study/NCT04633330 | https://clinicaltrials.gov/study/NCT04221516 | https://clinicaltrials.gov/study/NCT06069726 | https://clinicaltrials.gov/study/NCT03148795 | https://clinicaltrials.gov/study/NCT02528188 | https://clinicaltrials.gov/study/NCT03568539 | https://clinicaltrials.gov/study/NCT06290050 | https://clinicaltrials.gov/study/NCT04072107 | https://clinicaltrials.gov/study/NCT05862324 | https://clinicaltrials.gov/study/NCT03386942 | https://clinicaltrials.gov/study/NCT07227571 | https://clinicaltrials.gov/study/NCT00630149 | https://clinicaltrials.gov/study/NCT04241315 | https://clinicaltrials.gov/study/NCT06511037 | https://clinicaltrials.gov/study/NCT02872701 | https://clinicaltrials.gov/study/NCT06609928 | https://clinicaltrials.gov/study/NCT04928612 | https://clinicaltrials.gov/study/NCT01684098 | https://clinicaltrials.gov/study/NCT02499614 | https://clinicaltrials.gov/study/NCT03147976 | https://clinicaltrials.gov/study/NCT06762327